High Throughput Extraction of Plant, Marine and Fungal Specimens for Preservation of Biologically Active Molecules

The Developmental Therapeutics Program (DTP) of the U.S. National Cancer Institute (NCI), at its NCI-Frederick facility, has built perhaps the largest and most diverse natural products screening library in the world for drug discovery. Composed of plant, marine organism and microbial extracts, it currently contains in excess of 230,000 unique materials. From the inception of this program to identify new anticancer chemotherapeutics from natural products sources in 1987, two extracts have been sequentially prepared from each specimen: one produced by organic solvent extraction, which yields a complex material that contains non- to moderately polar small molecules, and a water-soluble extract, a milieu largely unexplored for useful drugs in earlier years, which contains polar small to medium-sized molecules. Plant specimens and microbial ferments are extracted by modified traditional methods, while the method developed to produce extracts from marine organisms is unique and very different from that used by marine natural products chemists previously, but again yields both an organic solvent soluble and a water soluble material for inclusion into the screening library. Details of high throughput extract production for preservation of biologically active molecules are presented.

[1]  D. E. Nichols,et al.  Brine shrimp: a convenient general bioassay for active plant constituents. , 1982, Planta medica.

[2]  D. Scudiero,et al.  Cytotoxic and HIF-1alpha inhibitory compounds from Crossosoma bigelovii. , 2009, Journal of natural products.

[3]  A. McPhail,et al.  Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. , 1971, Journal of the American Chemical Society.

[4]  Sudhir Varma,et al.  DNA fingerprinting of the NCI-60 cell line panel , 2009, Molecular Cancer Therapeutics.

[5]  Gordon M. Cragg,et al.  Distribution of phorbol ester bioactivity in the euphorbiaceae , 1989 .

[6]  R. Shoemaker,et al.  Aspirochlorine class compounds from Aspergillus flavus inhibit azole-resistant Candida albicans. , 2005, Journal of natural products.

[7]  L K Pannell,et al.  Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development , 1997, Antimicrobial agents and chemotherapy.

[8]  A. McPhail,et al.  Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata1,2 , 1966 .

[9]  David J Newman,et al.  Natural products as sources of new drugs over the period 1981-2002. , 2003, Journal of natural products.

[10]  R. Fuller,et al.  Frequent Occurrence of HIV-Inhibitory Sulphated Polysaccharides in Marine Invertebrates , 1993 .

[11]  R. Gereau,et al.  Ancistrocladus korupensis (Ancistrocladaceae): A new species of liana from Cameroon , 1993 .

[12]  M. Boyd,et al.  Ibisterol sulfate, a novel HIV-inhibitory sulfated sterol from the deep water sponge Topsentia sp. , 1993 .

[13]  M. Okuhara,et al.  FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No. 968. I. Taxonomy, fermentation, isolation, physico-chemical and biological properties, and antitumor activity. , 1994, The Journal of antibiotics.

[14]  Barry R O'Keefe,et al.  Isolation and Characterization of Griffithsin, a Novel HIV-inactivating Protein, from the Red Alga Griffithsia sp.* , 2005, Journal of Biological Chemistry.

[15]  W. Abraham,et al.  Penicillium camemberti A New Source of Brefeldin A , 1992, Planta medica.

[16]  A. J. Ullstrup,et al.  Decumbin, a New Compound from a Species of Penicillium , 1958, Nature.

[17]  J. McLaughlin,et al.  Asimicin, a new cytotoxic and pesticidal acetogenin from the pawpaw, Asimina triloba (Annonaceae) , 1986 .

[18]  K. Gustafson,et al.  HIV-inhibitory coumarins from latex of the tropical rainforest tree Calophyllum teysmannii var. inophylloide , 1994 .

[19]  Lori L. Rodgers,et al.  The large-scale isolation of bryostatin 1 from Bugula neritina following current good manufacturing practices. , 1991, Journal of natural products.

[20]  K. Poole,et al.  Production of brefeldin-A , 1995, Journal of Industrial Microbiology.

[21]  I. Kawamura,et al.  FR901228, a Novel Antitumor Bicyclic Depsipeptide Produced by Chromobacterium violaceum No. 968. Part 3. Antitumor Activities on Experimental Tumors in Mice. , 1994 .

[22]  L. Pannell,et al.  Isolation and characterization of novel cytotoxic saponins from Archidendron ellipticum. , 1997, Bioorganic & medicinal chemistry.

[23]  D A Scudiero,et al.  Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. , 1988, Cancer research.

[24]  L. Pannell,et al.  The Lobatamides, Novel Cytotoxic Macrolides from Southwestern Pacific Tunicates† , 1998 .

[25]  John H Cardellina,et al.  Identification of a new natural camptothecin analogue in targeted screening for HIF-1alpha inhibitors. , 2006, Planta medica.

[26]  K. Gustafson,et al.  The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum. , 1992, Journal of medicinal chemistry.

[27]  M. Boyd,et al.  Novel alkaloids from the tropical plant Ancistrocladus abbreviatus inhibit cell killing by HIV-1 and HIV-2. , 1991, Journal of medicinal chemistry.

[28]  H. Tanaka,et al.  FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No. 968. II. Structure determination. , 1994, The Journal of antibiotics.

[29]  R. Shoemaker,et al.  A novel antimicrobial indolizinium alkaloid from Aniba panurensis. , 2004, Journal of natural products.

[30]  M R Grever,et al.  In vivo cultivation of tumor cells in hollow fibers. , 1995, Life sciences.